Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/14694
Title: Development and validation of modern chromatographic methods for analysis of pharmaceutical drug products
Researcher: Navaneethan G
Guide(s): Karunakaran K
Keywords: Pharmaceutical drug products, chromatographic techniques, HPLC, UPLC
Upload Date: 6-Jan-2014
University: Anna University
Completed Date: 
Abstract: Pharmaceutical drug products play a vital role in human progress by finding curing for diseases. Today, a majority of the drugs used are of synthetic origin. They are produced in bulk and used for their therapeutic effects in pharmaceutical formulations. These formulations deliver the drug substances in a stable, non-toxic and acceptable form, ensuring its bio-availability and therapeutic activity. The end user of the drug product has to be assured of the medicine s quality, which makes suitable testing of the materials an area of great concern. Thus, the analytical activities concerning purities in drug products are among the most important issues in modern pharmaceutical analysis. This subject or topic for this research activity is selected based on the increasing need for the pharmaceutical industry to develop suitable analytical methods. Among various other available techniques, the scope of work was focused on the modern chromatographic techniques such as HPLC and UPLC, which are very powerful and sophisticated techniques and have a wide spectrum of applications in the pharmaceutical industry. Five chromatographic methods were developed for different pharmaceutical drug products. The first method was developed for the estimation of pioglitazone, glimepiride and glimepiride impurities, i.e., related compound B and related compound C from combination drug product containing pioglitazone, glimepiride and metformin hydrochloride. The second method was developed for the estimation of nevirapine and its impurities in combination drug product containing lamividune, zidovudine and nevirapine. The third method was developed for the estimation of rabeprazole sodium in formulated drug product containing rabeprazole sodium. The fourth method was developed for the estimation of pioglitazone, glibenclamide, and glibenclamide impurities A and B from combination drug product. The fifth method was developed for the estimation of paracetamol, tramadol hydrochloride and domperidone in combination drug product. newline newline newline
Pagination: xxi, 163
URI: http://hdl.handle.net/10603/14694
Appears in Departments:Faculty of Science and Humanities

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File70.56 kBAdobe PDFView/Open
02_certificate.pdf59.81 kBAdobe PDFView/Open
03_abstract.pdf53 kBAdobe PDFView/Open
04_acknowledgement.pdf57.29 kBAdobe PDFView/Open
05_contents.pdf123.66 kBAdobe PDFView/Open
06_chapter 1.pdf2.34 MBAdobe PDFView/Open
07_chapter 2.pdf1.56 MBAdobe PDFView/Open
08_chapter 3.pdf1.41 MBAdobe PDFView/Open
09_chapter 4.pdf314.58 kBAdobe PDFView/Open
10_chapter 5.pdf1.43 MBAdobe PDFView/Open
11_chapter 6.pdf784.85 kBAdobe PDFView/Open
12_references.pdf99.84 kBAdobe PDFView/Open
13_publications.pdf60.4 kBAdobe PDFView/Open
14_vitae.pdf43.42 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.